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Abstract: A methyl ester of L-mandelic acid was found to be an effective resolving agent for 
resolution of commercial DL-isoleucine. The resolution was based on Steglich esterification between 
methyl L-mandelate and Boc-DL-isoleucine. The two resolved isomers were easily separated by using 
a conventional flash-column chromatography, giving quantitatively good yields. Unfortunately, the 
methyl L-mandelate was found to be ineffective to resolve four stereoisomers of Fmoc- isoleucine. 
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Abstrak: Ester metil L-mandelat diketahui merupakan agen pemisah yang efektif dalam resolusi 
campuran rasemat DL-isoleusin komersial. Proses resolusi didasarkan pada reaksi esterifikasi 
Steglich antara metil L-mandelat dan Boc-DL-isoleusin. Dua stereoisomer yang telah dipisahkan 
dapat dengan mudah dipisahkan dan menghasilkan produk dengan perolehan hasil yang baik. 
Sayangnya, metil L-mandelat diketahui tidak efektif untuk memisahkan campuran empat stereoisomer 
dari Fmoc-isoleusin. 
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INTRODUCTION  
L-allo-Isoleucine (L-aIle) and D-isoleucine (D-
Ile) occur as residues in some natural peptides, 
including aureobasidins. L-aIle is one of the nine 
residues in almost all aureobasidins structures and is 
an important requirement forantifungal activity 
(Takesako et al., 1996). D-Ile was needed as the 
starting material for the preparation of D-Hmp, one 
of the residues in the aureobasidin structures. Both 
compounds are commercially available but very 
expensive. It is likely that the difficulty in accessing 
these two isomers of isoleucine is one of the 
problems, which limits the total synthesis of many 
peptides including the aureobasidins. Many attempts, 
to address the problem by the synthesis and 
resolution of isoleucine mixtures, have been 
accomplished by researchers since the 1900s. 
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Scheme 1. Resolution of formylated isoleucine mixtures with brucine by Aderhalden & Zeisset (1931) 
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In 1907, Locquin described the resolution of a 
formylated mixture of L-Ile and D-Ile using brucine 
as a resolving agent (Locquin, 1907). Nearly 25 years 
later, the four stereoisomers of isoleucine were 
successfully resolved by Aderhalden & Zeisset 
(1931) by the same method (Scheme 1). In the thesis 
of Hiatt from Illinois University in 1936 (Maharani, 
2013), a formylated isoleucine mixture was resolved 
by using brucine,where each resolved isomer was 
epimerized by hot baryta (barium solution) to be 
resolved further by brucine to give the four 
stereoisomers of isoleucine. Greenstein et al. (1951) 
obtained all four isomers from enantiomers of 
isoleucine including DL-isoleucine and DL-allo-
isoleucine. Acetylation of enantiomers was followed 
by epimerization and enzymatic resolution. However, 
the development and scale up of this technique was 
difficult. At the same time, Huffman & Ingersoll 
(1951) prepared acetylated enantiomers to be 
epimerized and then took advantage of (-)-α-
fenchylamine in water to resolve acetylated DL-Ile. 
Another resolving agent, (-)-α-phenylethylamine was 
found to be ineffective to separate the acetylated DL-
isomers. Acetylated-DL-aIle was only able to be 
resolved by using quinine in acetone. Other resolving 
agents, such as (-)-α-fenchylamine, (-)-α-
phenylethylamine, brucine, cinchonine, (-)-ephedrine 
and (-)-desoxyephedrine, were not useful for the 
resolution of the acetylated-DL-aIle. More recently, 
Flouret & Nakagawa (1975) used a pure isomer to get 
an isomer mixture through epimerization. The 
authors protected the isomer with several protecting 
groups such as isobutyryl (Ibu), carbonylbenzyloxy 
(Cbz) and Boc. The protected isomer was epimerized 
to get a mixture which was then resolved by using 
(S)- or (R)-phenylethylamine. 
All of the techniques described to date do not 
offer a simple, low cost and reliable method for the 
resolution of isoleucine mixtures. Most of the time 
these methods give a low yield of desired product. 
Due to these problems, a simple and inexpensive 
synthetic method for the resolution of an isoleucine 
mixture was desired. This work was interested in 
trialling methyl-L-mandelate as a resolving agent, 
which is easily prepared from an inexpensive starting 
material.  
Based on the literatures, the four isomers of 
isoleucine were obtained through epimerization of 
enantiomers (Hiatt 1936; Greenstein et al. 1951). 
Some researchers synthesised all four isomers, 
however most efforts could only produce two 
isomers. In the present study, we used a synthesis 
method of all four isomers described by Doyle et al. 
(1955). 
 
MATERIALS AND METHODS 
Optical rotation was measured with a Perkin-
Elmer 141 Polarimeter or Atago POLAX-2L 
polarimeter at the D line of sodium (589 nm) in a 1 
dm tube at the temperature and in the solvent 
indicated. 
NMR spectra were performed on a BrukerAvance 
300 (300.13 MHz) instrument or a BrukerAvance 
500 (500.19 MHz) instrument. 
1
H NMR were 
performed at 300.13 MHz or 500.19 MHz and 
13
C 
were obtained at 75 MHz or 125 MHz (La Trobe 
University). Deuterochloroform (Cambridge Isotope 
Laboratories Inc.) was used as a solvent and as an 
internal standard unless otherwise stated. Chemical 
shifts were reported as δ values in parts per million 
(ppm) and coupling constants (J) in Hz.  
Low Resolution-Electrospray Ionisation Mass 
Spectrometry (LR-ESI) was carried out using a 
Bruker Daltonics (Germany) Esquire 6000 ion trap 
mass spectrometer at 300°C with a scan rate 5500 
m/z/sec that was carried out at the Mass 
Spectrometry & Proteomics Facility, La Trobe 
University. The molecular weights of all compounds 
were calculated based on calculations performed by 
Chem Draw Ultra V12.0. 
 
Procedures 
 
(S,R)-[(t-Butoxycarbonyl)amino]-3(S,R)-3-
methylpentanoic acid (2) 
Commercially available DL-isoleucine mixture 1 
(131 mg, 1.00 mmol) was dissolved in water (2 mL). 
To this solution was added 1 M sodium hydroxide (2 
mL) and the solution was stirred and cooled to 5°C. 
To the chilled solution was added Boc-anhydride 
(327 mg, 1.50 eq) in dioxane (5 mL) and cooling was 
continued. The reaction mixture was cooled at 0°C 
for 1 h and then it was allowed to warm to room 
temperature overnight. To this mixture was added 
water and the solution was extracted with ethyl 
acetate. The organic layer was back-washed with 
saturated sodium bicarbonate solution and the 
combined aqueous layers were acidified to pH 1 by 
the addition of 10% hydrochloric acid solution and 
then it was extracted with ethyl acetate. The organic 
solution was dried (MgSO4) and concentrated to give 
carbamate 2 as a colourless oil (46.0 mg). Yield: 
80%; 
1
H-NMR (300 MHz, CDCl3) δH (ppm) 
(rotamers) 9.65 (1H, bs, COOH), 5.09 (1H, d, J = 8.4 
Hz, NH), 5.03 (1H, d, J = 9 Hz, NH), 4.37-4.04 (1H, 
m, COCHNH), 1.89 (1H, bs, CH3CHCH2), 1.40 (9H, 
s, C(CH3)3),1.48-1.36 (1H, m,CHCHHCH3), 1.24-
1.10 (1H, m, CHCHHCH3), 0.93-0.82 (6H, m; 
CH3CH, CH3CH2); 
13
C-NMR (75 MHz, CDCl3) δC 
(ppm) 174.1, 174.0, 146.2, 84.7, 78.8, 57.3, 56.1, 
37.4, 37.2, 28.5, 27.8, 25.7, 24.5, 15.0, 13.9, 11.3, 
11.2. 
 
(S)-Methyl 2-hydroxy-2-phenylacetate (4) 
To a stirred solution of L-mandelic acid 3 (1.52 g, 
10.00 mmol) in methanol (25 mL) was added 
concentrated sulfuric acid (200 µL). The reaction 
mixture was refluxed for 3 h and then cooled to room 
temperature. To this mixture was added sodium 
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bicarbonate (1-2 g) to neutralize any excess acid. 
Then, water was added and the solution was extracted 
with dichloromethane (3 × 5 mL). The organic layer 
was dried with MgSO4, filtered and evaporated to 
give ester 4 as white crystals (1.15 g).Yield: 69%; 
m.p. 51-53°C (lit.(Sigma-Aldrich) 56-58 
oC); [α]D
20
 = 
+150, c = 2 in methanol (lit.(Sigma-Aldrich) [α]D
20
 = 
+144, c = 1 in methanol); ESI-MS m/z [M+Na]
+
 
189.0 (100%); 
1
H-NMR (300 MHz, CDCl3) δH (ppm) 
7.41-7.28 (5H, m, ArH), 5.16 (1H, s, ArCH(OH)CO), 
3.74 (3H, s, OCH3), 3.49 (1H, bs, OH); 
13
C-NMR (75 
MHz, CDCl3) δC (ppm) 173.7, 137.9, 128.2, 128.1, 
126.2, 72.5, 52.6.  
 
(2S,3R)-(S)-2-Carbomethoxy-1-phenylethyl 2-[(t-
butoxycarbonyl)amino]-3-methylpentanoate (5a) 
To a flask equipped with a calcium chloride 
drying tube, was added a solution of 2 (450 mg, 1.95 
mmol) in dichloromethane (6 mL) and then ester 4 
(324 mg, 1.95 mmol) and 4-dimethylaminopyridine 
(190 mg, 1.56 mmol). This stirred solution was 
cooled in an ice bath (0°C). To this solution was 
added N,N’-dicyclohexylcarbodiimide (805 mg, 3.9 
mmol) over a 5 min period and stirring was continued 
for 5 min. Stirring was then continued for 4 h at room 
temperature. The solution was filtered and the filtrate 
was washed with 0.5 N hydrochloric acid and then 
with saturated sodium bicarbonate solution. The 
organic layer was dried (MgSO4) and evaporated to 
give a residue. The residue was purified by flash 
column chromatography (hexane-ethyl acetate) 
resulting in isolation of two diastereoisomers, 5a 
(190 mg) and 5b (222 mg) as colourless oils. 5a 
Yield: 25%; [α]D
20
 = +27.5, c = 2 in dichloromethane; 
1
H-NMR (300 MHz, CDCl3) δH (ppm) 7.42-7.36 (5H, 
m, ArH), 5.91 (1H, s, ArCHO), 4.95 (1H, d, J = 9.0 
Hz, COCHNH), 4.50-4.47 (1H, m, COCHNH), 3.69 
(3H, s, OCH3), 2.13 (1H, bs, CH3CHCH2), 1.38 (9H, 
s, C(CH3)3), 1.52-1.21 (2H, m, CHCH2CH3), 0.98-
0.93 (6H, m, CH3CH, CH3CH2); 
13
C-NMR (75 MHz, 
CDCl3) δC (ppm) 172.0, 168.6, 155.3, 132.9, 128.9, 
128.4, 127.2, 79.6, 74.5, 56.1, 52.1, 37.1, 27.9, 25.9, 
13.7, 11.4. 5b Yield: 30%; [α]D
20
 = +32.5, c = 2 in 
dichloromethane; 
1
H-NMR (300 MHz, CDCl3) δH 
(ppm) 7.43-7.35 (5H, m, ArH), 5.95 (1H, s, ArCHO), 
4.96-4.92 (1H, m, COCHNH), 4.42-4.38 (1H, m, 
COCHNH), 3.71 (3H, s, OCH3), 1.91 (1H, bs, 
CH3CHCH2), 1.41 (2H, d, J = 2.7 Hz, CHCH2CH3), 
1.38 (9H, s, C(CH3)3), 0.98-0.90 (3H, m, CH3CH), 
0.84 (3H, t, J = 7.2 Hz, CH3CH2); 
13
C-NMR (75 
MHz, CDCl3) δC (ppm) 171.0, 168.4, 155.0, 133.2, 
128.9, 128.3, 127.2, 79.4, 74.4, 57.6, 52.2, 37.5, 27.8, 
24.4, 15.0, 11.7. 
 
(2S,3R)-Methyl 2-[(t-butoxycarbonyl)amino]-3-
methylpentanoate (6a)  
Under an N2 atmosphere, 5a (190 mg) and 
potassium carbonate (2 grains) were dissolved in 
methanol (12 mL). The progress of the reaction was 
monitored by TLC. After the reaction was complete, 
the reaction mixture was dissolved in 
dichloromethane and extracted with water. The 
organic phase was purified using flash column 
chromatography (hexane:ethyl acetate) and this 
afforded 6a as a colourless oil (84.0 mg). Yield: 68%; 
[α]D
20
 = +14.75, c = 2 in methanol; ESI-MS m/z 
[M+K]
+
 284.0 (100%)]; 
1
H-NMR (300 MHz, CDCl3) 
δH (ppm) 4.94 (1H, d, J = 9.0 Hz, COCHNH), 4.31 
(1H, dd, J = 9.0, 3.6 Hz, COCHNH), 3.70 (3H, s, 
CH3O), 1.88-1.80 (1H, m, CH3CHCH2), 1.40 (9H, s, 
C(CH3)3), 1.45-1.31 (1H, m, CHCHHCH3), 1.19-1.07 
(1H, m, CHCHHCH3), 0.90 (3H, t, J = 10.2 Hz, 
CH3CH), 0.83 (3H, d, J = 5.2 Hz, CH3CH2); 
13
C-
NMR (75 MHz, CDCl3) δC (ppm) 172.9, 155.4, 79.4, 
56.4, 51.6, 37.3, 27.9, 25.7, 14.0, 11.3.  
 
(2R,3S)-Methyl 2-[(t-butoxycarbonyl)amino]-3-
methylpentanoate (6b) 
A similar procedure was carried out on 5b (222 
mg) to give 6b as a colourless oil (59.0 mg). Yield: 
41%; [α]D
20 
= -11.11, c = 1 in methanol; ESI-MS m/z 
[M+K]
+
 284.1 (100%)];  
1
H-NMR (300 MHz, 
CDCl3) δH (ppm) 5.00 (1H, d, J = 7.5 Hz, 
COCHNH), 4.33-4.20 (1H, m, COCHNH), 3.72 (3H, 
s, CH3O), 1.80-1.75 (1H, bs, CH3CHCH2), 1.43 (9H, 
s, C(CH3)3), 1.49-1.32 (1H, m, CHCHHCH3), 1.20-
1.06 (1H, m, CHCHHCH3) 0.92-0.78 (6H, m, 
CH3CH, CH3CH2); 
13
C-NMR (75 MHz, CDCl3) δC 
(ppm) 172.5, 155.1, 79.3, 57.4, 51.5, 37.6, 27.9, 24.6, 
15.0, 11.1.  
The four isomers of isoleucine were synthesized 
via a two-step literature method (Doyle et al. 1955).  
 
(E)-4-(Butan-2-ylidene)-2-phenyloxazol-5(4H)-one 
(10) 
To a solution of hippuric acid (20.0 g, 110 mmol) 
and anhydrous sodium acetate (9.00 g, 110 mmol) in 
methyl ethyl ketone (478 mL) was added acetic 
anhydride (28 mL) dropwise during a 30 min period. 
Then, the solution was refluxed for 2 h. The resulting 
orange solution was distilled to recover the methyl 
ethyl ketone (b.p. 80-84°C). The residual solution 
was evaporated and the residue was dissolved in 
saturated sodium bicarbonate solution until 
effervescence ceased and then it was extracted with 
ether. The organic layer was evaporated to give a 
crude. This crude was purified on a flash 
chromatography column eluting with 4% ethyl 
acetate in hexane to give compound 10 as a yellow 
oil (7.35 g). Yield: 32%; ESI-MS m/z [M+H]
+
 216.2 
(100%); 
1
H-NMR (300 MHz, CDCl3) δH (ppm) 8.03 
(2H, d, J = 6.9 Hz, ArH), 7.55-7.43 (3H, m, ArH), 
2.86 (1H, q, J = 7.5 Hz, CCHHCH3), 2.75 (1H, q, J = 
7.5 Hz, CCHHCH3), 2.35 (3H, bs, CH3C), 1.25-1.13 
(3H, m, CH3CH2); 
13
C-NMR (75 MHz, CDCl3) δC 
(ppm) 165.4, 164.7, 159.1, 159.0, 158.8, 158.4, 
132.0, 131.9, 130.9, 130.8, 128.4, 127.3, 127.2, 
125.8, 28.7, 25.7, 19.7, 16.9, 12.0, 11.8. 
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Isoleucine mixture (11) 
To a solution of 10 (2.71 g, 12.6 mmol) in acetic 
acid (17.8 mL) was added hydroiodic acid (12.7 mL, 
55%) and red phosphorus (760 mg). The reaction 
mixture was then refluxed for 90 min and the reaction 
mixture was filtered and evaporated to give a crude 
that was partitioned between water and ether. The 
aqueous layer was evaporated and the residue was 
dissolved in ethanol. The solution was then adjusted 
to pH 6. The white precipitate that formed was 
removed by filtration. Then calcium hydroxide (1.40 
g) in water was added to the white precipitate and the 
solution was heated until boiling for 1 h. To remove 
the calcium from the filtrate, the filtrate was then 
treated with ammonium bicarbonate and filtered. 
Evaporation of the filtrate resulted in 11 (510 mg, 
21% yield). 
 
2-[(N-Fluorenylmethyloxycarbonyl)amino]-3-
methylpentanoic acid (12) 
An isoleucine mixture 11 (1.00 g, 7.60 mmol) 
was dissolved in aqueous sodium hydroxide (304 mg, 
76.0 mmol in 38 mL water). To this solution was 
added N-(9-fluorenylmethoxycarbonyloxy) 
succinimide (2.56 g, 7.60 mmol) in acetone (38 mL) 
in several portions. Once the addition was complete, 
sodium bicarbonate (638 mg, 7.60 mmol) was added 
to the solution. The solution was stirred until it turned 
clear. The clear solution was cooled and adjusted to 
pH 2 by the addition of concentrated hydrochloric 
acid. Then the solution was partitioned between 
saturated sodium bicarbonate solution and ethyl 
acetate. The organic solution was dried (MgSO4) and 
concentrated to give 12 (1.91 g).Yield: 71%; ESI-MS 
m/z [M+Na]
+
 376.1 (100%); 
1
H-NMR and 
13
C-NMR 
showed a mixture of isoleucines. 
 
(2S,3R)-(S)-2-Methoxy-2-oxo-1-phenylethyl-2- 
[(N-fluorenylmethyloxycarbonyl)amino]-3-
methylpentanoate (13a) 
To a flask equipped with a calcium chloride 
drying tube was added a solution of 12 (1.77 g, 5.01 
mmol) in dichloromethane (18 mL), 4 (2.54 g, 15.3 
mmol) and 4-dimethylaminopiperidine (500 mg, 3.01 
mmol). This stirred solution was cooled in an ice bath 
(0°C) and to this solution was added N,N’-
dicyclohexylcarbodiimide (1.05 g, 5.01 mmol) over a 
5 min period. Stirring was then continued for 4 h at 
room temperature. The solution was filtered and the 
filtrate was washed successively with 0.5 N 
hydrochloric acid and saturated sodium bicarbonate 
solution. The organic layer was dried (MgSO4) and 
evaporated to give a residue. The residue was 
purified by flash column chromatography 
(dichloromethane:hexane:ethyl acetate = 3.5:6:0.5 
which was followed by 10-20% ethyl acetate in 
hexane) resulting in two diastereoisomers, 13a (795 
mg) and 13b (300 mg) as colourless oils. 13a Yield: 
40%; [α]D
20
 = +60.0, c = 1 in dichloromethane; ESI-
MS m/z [M+H]
+
 502.1 (100%); 
1
H-NMR (300 MHz, 
CDCl3) δH (ppm) 7.75 (2H, d, J = 7.5 Hz, ArH), 7.59 
(2H, d, J = 7.2 Hz, ArH), 7.44-7.36 (7H, m, ArH), 
7.27 (2H, t, J = 7.2 Hz, ArH), 5.94 (1H, s, ArCHO), 
4.64 (1H, dd, J = 4.5, 9.0 Hz, OCHHCH), 4.38 (2H, 
d, J = 6.9 Hz, OCHHCH; ArCHAr), 4.22 (1H, t, J = 
6.9 Hz, COCHNH), 3.71 (3H, s, CH3O),2.18 (1H, bs, 
CH3CHCH2), 1.59-1.49 (1H, m, CHCHHCH3), 1.39-
1.22 (1H, m, CHCHHCH3), 1.06-0.85 (6H, m, 
CH3CH; CH3CH2); 
13
C-NMR (75 MHz, CDCl3) δC 
(ppm) 171.2, 168.5, 155.7, 143.6, 143.4, 140.9, 
132.9, 129.1, 128.5, 127.3, 127.2, 126.7, 124.8, 
119.6, 74.8, 66.8, 57.9, 52.3, 46.8, 37.8, 24.4, 14.9, 
11.4. 13b Yield: 17 %;  [α]D
20
 = +45.0, c = 1 in 
dichloromethane; ESI-MS m/z [M+H]
+
 502.1 
(100%);  
1
H-NMR (300 MHz, CDCl3) δH  (ppm) 7.71 
(1H, d, J = 7.2 Hz, ArH), 7.66 (2H, d, J = 7.8 Hz, 
ArH), 7.59 (1H, d, J = 7.2 Hz, ArH), 7.45-7.40 (7H, 
m, ArH), 7.30 (2H, t, J = 6.9 Hz, ArH), 5.97 (1H, d, J 
= 14.4 Hz, ArCHO), 4.74-4.56 (1H, m, OCHHCH), 
4.39 (2H, d, J = 6.6 Hz, OCHHCH; ArCHAr), 4.23 
(1H, t, J = 6.9 Hz, COCHNH), 3.71 (3H, s, CH3O), 
2.19 (1H, bs, CH3CHCH2), 1.63-1.38 (1H, m, 
CHCHHCH3), 1.36-1.23 (1H, m, CHCHHCH3), 1.10-
0.97 (6H, m, CH3CH; CH3CH2); 
13
C-NMR (75 MHz, 
CDCl3) δC (ppm) 171.6, 168.5, 156.1, 143.6, 143.4, 
140.9, 132.8, 129.7, 129.1, 128.6, 128.5, 127.3, 
126.7, 124.7, 119.6, 74.7, 66.8, 56.8, 52.3, 46.8, 37.7, 
24.2, 13.8, 11.4. 
 
RESULTS AND DISCUSSION 
Resolution of Boc-DL-isoleucine 
In the first attempt, commercially available DL-
isoleucine 1 was initially protected with Boc-
anhydride to give Boc-isoleucine 2 (Scheme 2). Boc- 
and Fmoc-protected amino acids are preferred, as 
these compounds are then ready for either solution- 
or solid-phase peptide synthesis. The DL-isoleucine 
was protected based on a reported protocol 
(Umezawa et al. 2010) affording 91% yield of the 
product, which was confirmed by 
1
H- and 
13
C-NMR 
which showed the desired compound. The presence 
of a methyl signal at H 1.40 ppm ( C 27.8 and 28.5 
ppm) and one additional carbonyl signal at C 146.2 
ppm supported the presence of the Boc group. 
The resolving agent of methyl L-mandelate 4 was 
prepared from L-mandelic acid 3 employing a simple 
Fisher acidic esterification and this gave a good yield 
of the corresponding ester 4 (Scheme 3). The 
presence of a singlet signal in the 
1
H-NMR spectrum 
at δH 3.70 ppm and in the 
13
C-NMR spectrum at C 
52.6 ppm confirmed the presence of the methyl ester. 
Boc-isoleucine 2 was reacted with methyl L-
mandelate 4 by taking advantage of the Steglich 
esterification (Neises & Steglich 1978) using 
DCC/DMAP in dichloromethane (Scheme 4) (Neises 
& Steglich 1990).  
The Steglich esterification method was chosen 
because the mildly basic conditions were compatible 
with the Boc protecting group. The reaction between 
Boc-isoleucine 2 and methyl L-mandelate 4 resulted 
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Scheme 2 Boc-protection of DL-isoleucine, (a) H2O, NaOH, (Boc)2O. 
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Scheme 3 A preparation of methyl L-mandelate 4, (a) methanol, sulfuric acid. 
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Figure 1 Structures of DCC 7 and DMAP 8. 
 
in formation of two diastereomers of the mandelic 
esters 5a and 5b which were subsequently separated 
by flash column chromatography in 25% and 30% 
yield, respectively. 
DCC 7 is a carbodiimide-based coupling reagent 
that is useful for the preparation of esters and amides 
(Figure 1). This reagent was reported by Sheehan & 
Hess (1955) as being insensitive to moisture, without 
racemised products and resulting in a separable by-
product, N,N’-dicyclohexyl urea, that has low 
solubility both in organic and aqueous phase. 
However, due to the insoluble by-product, DCC-
based coupling reactions are inappropriate for solid-
phase peptide synthesis. 
DMAP 8 (Figure 1) was added as a catalyst in 
order to activate the O-acylisourea intermediate 
(Neises & Steglich 1978). This compound acts as an 
acyl transfer reagent and a subsequent reaction with 
an alcohol results in ester bond formation (Corey 
2007). Unfortunately, undesirable levels of 
racemization can be produced when employed in 
excess and it has been shown that no more than 0.15 
equivalents should be used (ChemPrep 2005; 
AAPPTec 2011). In DCC/DCI-mediated reactions, 
dichloromethane has been proven to be the optimal 
solvent for carbodiimide activation. A mixture of 
dichloromethane and DMF is often used for both the 
activation and the coupling steps.  
Mechanistic studies on the Steglich esterification 
have been reported (Corey 2007). An O-acylisourea 
intermediate results from reaction between DCC and 
a carboxylic acid and this gives reactivity that is 
similar to the carboxylic acid anhydride. The 
intermediate was further activated by DMAP 8. 
DMAP 8 is a strong nucleophile that is more reactive 
than the alcohol itself and reacts with the O-
acylisourea affording a reactive amide. The alcohol 
then adds to the activated carbonyl of the reactive 
amide to form the stable dicyclohexylurea (DHU) 
and the ester (Figure 2). 
 
Table 1. Optical rotation data of Boc-protected 
isoleucine 
 
Compound [α]20D 
Boc-L-Ile methyl ester 6a +14.75 (c 2 in methanol) 
Boc-L-Ile methyl ester*  +16.6 (c 2 in chloroform) 
Boc-D-Ile methyl ester 6b -11.11 (c 1 in methanol) 
*Widmer & Lorenzi (1971) 
 
Methanolysis of each of the diastereomers 5a and 
5b resulted in the corresponding methyl esters 6a and 
6b (Scheme 4). Measurement of the optical rotation 
of the compounds also gave useful information 
(Table 1). The optical rotation value of the Boc-L-Ile 
methyl ester 6a in methanol was found to be close to 
the value of the same compound measured in 
chloroform. Both compounds were purified by flash 
chromatography and each was shown to be a single 
compound by 
1
H- and particularly 
13
C-NMR that 
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Figure 2. A mechanism for Steglich esterification between Boc-DL-isoleucine 2 and methyl L-mandelate 4 
(adapted from Corey et al. 2007).  
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Scheme 4. Steglich esterification between Boc-DL-isoleucine 2 and methyl L-mandelate 4 and resolution of 
products, (a) CH2Cl2, DCC, DMAP. (b) K2CO3, methanol. 
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showed a single set of peaks, which is a good sign to 
be a single stereoisomer. 
Similar work carried out by Dumbre (2010 in 
Maharani 2013) using Fmoc-DL-isoleucine also 
found only two enantiomers from the 
chromatographic separation. Based on both of these 
initial investigations, it appeared that methyl L-
mandelate 4 as a resolving agent was effective to 
achieve resolution of the isomers. To further study 
the ability of methyl L-mandelate 4 to resolve an 
isoleucine mixture, the developed resolution protocol 
was tested using a synthetic isoleucine mixture. 
 
Resolution of four stereoisomers of Fmoc-
isoleucine 
Synthesis of a mixture of all four isoleucine 
isomers 11 was undertaken using the methodology 
developed by Doyle et al. (1955) This process occurs 
via an intermediate oxazolone 10 in 32% yield where 
reduction by red phosphorus and hydroiodic acid (HI) 
leads to the desired product mixture in 55% yield 
(Scheme 5). The presence of the four isomers 
resulted from this synthesis has also been confirmed 
by Aurelio et al. (2006). It had been shown by 
13
C-
NMR of the product mixture that doubling of all 
peaks with near equal intensity was occurring. All 
four possible isomers are shown in Figure 4. 
Fmoc protection was then carried out on the 
isoleucine mixture using Fmoc-O-succinimide in 
basic conditions in 67% yield (Scheme 6). Steglich 
esterification using DCC/DMAP with 4 resulted in 
mandelic esters 13. These were separated by flash 
chromatography. Unfortunately, the expected four 
isomers were not obtained. The product mixture 
could only be separated into two isomers, 13a in 40% 
yield and 13b in 17% yield (Scheme 6). 
Each isomer appeared to be a single enantiomer 
due to a single set of peaks shown in the 
1
H and 
particularly 
13
C-NMR spectra. The optical rotation of 
each isomer is shown in Table 2. In fact, there are no 
reference of optical rotation of the 13a and 13b, 
reported in the literature. It was assumed that 
isolation of the other two isomers probably failed 
during the purification step. In the purification step, 
13a and 13b were found to be two major isomers in 
the mixture, while the other two isomers might be 
remained as minor fractions, which are barely 
separated and analyzed. Another possibility was that 
the methyl L-mandelate 4 could not resolve the four 
isomers of isoleucine. 
 
 
N
H
OH
O
O
a
ON
OH3C
CH2CH3
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Scheme 5 Synthesis of the isoleucine mixture. (a) sodium acetate, methyl ethyl ketone, acetic anhydride. (b) 
acetic acid, HI, red phosphorus. 
 
 
 
Figure 4. Four isomers of isoleucine. 
 
Table 2. Optical rotation data of Fmoc-protected isoleucine 
 
Compound [α]20D 
Fmoc-L-Ile/aIle-methyl L-mandelate 13a +60.0 (c = 1 in dichloromethane) 
Fmoc-D-Ile/aIle-methyl L-mandelate 13b +45.0 (c = 1 in dichloromethane) 
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Scheme 6 A resolution of Fmoc-isoleucine mixture 11 with methyl-L-mandelate 4, (a) NaOH in water, Fmoc-
OSu in acetone, NaHCO3, (b) CH2Cl2, DCC, DMAP, 4. 
 
 
CONCLUSIONS 
The resolution of commercial DL-isoleucine was 
successfully undertaken by methyl L-mandelate 4. 
However, the resolving agent could not successfully 
resolve the four stereoisomers of isoleucine. Anew 
method that can cope with the problems in the 
resolution of isoleucine mixture still needs to be 
developed. 
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